$1.79
-0.13 (-6.77%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,280.4% upside
Low Target
$22.54
Average Target
$42.61
High Target
$49.20
Current Price
$1.79
Current
$1.79
$1.79
Target
$42.61
$42.61
$22.54
$42.61 avg
$49.20
Scenario Analysis
Bear Case
$22.54
1,159.2%
Low target
Base Case
$42.61
+2,280.4%
Avg target
Bull Case
$49.20
+2,648.6%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.56
-49.7% from high
52-Week Low
$1.05
+70.5% from low
Target vs 52W High
$42.61
+1,096.9% vs high
Next Earnings Report
May 20, 2026
2d
until earnings
EPS Est: $-0.54
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +22.4% |
| AMGN | Hold | 44 | 48% | $190.87 | -41.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +179.9% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +0.3% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.0% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -64.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -21.7% |
| BIIB | Buy | 43 | 56% | $91.45 | -52.6% |